Morgan Stanley Pyxis Oncology, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Morgan Stanley holds 153,248 shares of PYXS stock, worth $239,066. This represents 0.0% of its overall portfolio holdings.

Number of Shares

153,248

Previous 82,611 85.51%

Holding current value

$239,066

Previous $273,000 105.86%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.83 - $3.94 $199,902 - $278,309	70,637 Added 85.51%	153,248 $562,000
Q2 2024 Oct 17, 2024	BUY	$3.06 - $5.58 $119,597 - $218,088	39,084 Added 89.79%	82,611 $273,000
Q2 2024 Aug 14, 2024	BUY	$3.06 - $5.58 $119,597 - $218,088	39,084 Added 89.79%	82,611 $273,000
Q1 2024 Oct 17, 2024	SELL	$2.03 - $6.59 $79,340 - $257,563	-39,084 Reduced 47.31%	43,527 $185,000
Q1 2024 Aug 16, 2024	BUY	$2.03 - $6.59 $81,863 - $265,754	40,327 Added 1260.22%	43,527 $185,000
Q1 2024 May 15, 2024	BUY	$2.03 - $6.59 $81,863 - $265,754	40,327 Added 1260.22%	43,527 $185,000
Q4 2023 Aug 16, 2024	SELL	$1.4 - $2.09 $111,175 - $165,968	-79,411 Reduced 96.13%	3,200 $5,000
Q3 2023 Nov 15, 2023	BUY	$1.6 - $2.78 $4,320 - $7,505	2,700 Added 540.0%	3,200 $6,000
Q2 2023 Aug 14, 2023	SELL	$2.46 - $4.07 $413,466 - $684,069	-168,076 Reduced 99.7%	500 $1,000
Q1 2023 May 15, 2023	BUY	$1.38 - $6.0 $85,776 - $372,942	62,157 Added 58.41%	168,576 $675,000
Q4 2022 Feb 14, 2023	SELL	$1.14 - $2.0 $17,762 - $31,162	-15,581 Reduced 12.77%	106,419 $142,000
Q3 2022 Nov 14, 2022	SELL	$1.88 - $3.03 $27,968 - $45,077	-14,877 Reduced 10.87%	122,000 $240,000
Q2 2022 Oct 27, 2022	BUY	$2.02 - $4.53 $270,055 - $605,620	133,691 Added 4196.2%	136,877 $325,000
Q2 2022 Aug 15, 2022	BUY	$2.02 - $4.53 $270,055 - $605,620	133,691 Added 4196.2%	136,877 $325,000
Q1 2022 Oct 27, 2022	SELL	$4.04 - $11.43 $540,111 - $1.53 Million	-133,691 Reduced 97.67%	3,186 $12,000
Q1 2022 May 13, 2022	BUY	$4.04 - $11.43 $1,430 - $4,046	354 Added 12.5%	3,186 $12,000
Q4 2021 Feb 14, 2022	BUY	$8.39 - $13.64 $23,760 - $38,628	2,832 New	2,832 $31,000

Others Institutions Holding PYXS

# of Institutions

Shares Held

28.2M

Call Options Held

539K

Put Options Held

54.1K

View Full List

About Pyxis Oncology, Inc.

Ticker PYXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,096,400
Market Cap $54.8M
Description
Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...

More about PYXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account